HUE045444T2 - Polimer mircén kompozíciók - Google Patents

Polimer mircén kompozíciók

Info

Publication number
HUE045444T2
HUE045444T2 HUE10710912A HUE10710912A HUE045444T2 HU E045444 T2 HUE045444 T2 HU E045444T2 HU E10710912 A HUE10710912 A HU E10710912A HU E10710912 A HUE10710912 A HU E10710912A HU E045444 T2 HUE045444 T2 HU E045444T2
Authority
HU
Hungary
Prior art keywords
compositions
polymeric myrcene
myrcene
polymeric
Prior art date
Application number
HUE10710912A
Other languages
English (en)
Inventor
Zadik Hazan
Shimon Amselem
Original Assignee
Regenera Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regenera Pharma Ltd filed Critical Regenera Pharma Ltd
Publication of HUE045444T2 publication Critical patent/HUE045444T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/22Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
HUE10710912A 2009-03-04 2010-03-04 Polimer mircén kompozíciók HUE045444T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15721609P 2009-03-04 2009-03-04

Publications (1)

Publication Number Publication Date
HUE045444T2 true HUE045444T2 (hu) 2019-12-30

Family

ID=42536397

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE10710912A HUE045444T2 (hu) 2009-03-04 2010-03-04 Polimer mircén kompozíciók

Country Status (15)

Country Link
US (4) US8722105B2 (hu)
EP (2) EP2403512B1 (hu)
CN (2) CN102413834B (hu)
AU (1) AU2010220057C1 (hu)
BR (1) BRPI1013222B8 (hu)
CA (1) CA2754565C (hu)
DK (1) DK2403512T3 (hu)
EA (2) EA021833B1 (hu)
ES (1) ES2739033T3 (hu)
HK (1) HK1218710A1 (hu)
HU (1) HUE045444T2 (hu)
IL (2) IL214923A (hu)
PL (1) PL2403512T3 (hu)
TR (1) TR201911270T4 (hu)
WO (1) WO2010100651A2 (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2403512T3 (pl) 2009-03-04 2019-10-31 Regenera Pharma Ltd Kompozycje polimerowego mircenu
DK2403505T3 (en) 2009-03-04 2017-03-06 Regenera Pharma Ltd Therapeutic Applications of Mastic Rubber Fractions
ES2562807T3 (es) * 2009-10-28 2016-03-08 Regenera Pharma Ltd. Monoterpenos poliméricos para tratar la función neurológica alterada
ES2732559T3 (es) 2010-09-07 2019-11-25 Regenera Pharma Ltd Composiciones que comprenden extractos ácidos de almáciga
US8979797B2 (en) * 2010-12-16 2015-03-17 Ams Research Corporation High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics
ES2666857T3 (es) 2011-07-18 2018-05-08 Mor-Research Applications Ltd. Un dispositivo para ajustar la presión intraocular
CN102526163A (zh) * 2011-12-27 2012-07-04 浙江景岳堂药业有限公司 一种用于风痛灵中乳香和没药的提取方法
US20150246087A1 (en) * 2012-06-11 2015-09-03 Regenera Pharma Ltd. Extracts and therapeutic uses thereof
US10053603B2 (en) 2014-04-02 2018-08-21 Kraton Polymers U.S. Llc Block copolymers containing a copolymer myrcene block
US9458362B2 (en) 2014-04-02 2016-10-04 Kraton Polymers U.S. Llc Adhesive compositions containing a block copolymer with polymyrcene
IL237621A0 (en) * 2015-03-08 2015-06-30 Regenera Pharma Ltd Use of isolated fractions of the gum goddess to treat optic neuropathy
JP7031867B2 (ja) 2015-09-24 2022-03-08 レジネラ ファーマ リミテッド トリテルペノイドを含む組成物
EP3352767A4 (en) 2015-09-24 2019-04-03 Regenera Pharma Ltd. COMPOSITIONS WITH TRITERPENOIDS
US10548917B2 (en) * 2016-05-23 2020-02-04 Kaeco Group Inc. Supplement for the prevention and treatment of gastrointestinal distress in horses and other species
US11439676B2 (en) 2018-10-16 2022-09-13 Kaeco Group, Inc. Method for prevention or treating gastrointestinal distress in humans using mastic gum compositions
AU2017322653A1 (en) 2016-09-08 2019-04-04 Regenera Pharma Ltd. Compositions comprising triterpenoids and uses thereof for treating optic neuropathy
BR112019004500A2 (pt) 2016-09-08 2019-05-28 Regenera Pharma Ltd composições compreendendo extratos ácidos de goma de mastique e utilizações das mesmas para o tratamento de neuropatias óticas
IT201700016726A1 (it) * 2017-02-15 2018-08-15 Phytoitalia Srl Frazioni arricchite in terpeni esenti da politerpeni estratte dal mastice di chios, dispositivi cosmetici, nutraceutici e medici, e composizioni farmaceutiche che le contengono
WO2019170239A1 (en) 2018-03-08 2019-09-12 Phytoitalia Srl Terpene enriched fractions free from polyterpenes extracted from chios mastic gum and cosmetic, nutraceutical, medical devices and pharmaceutical compositions containing them
CA3117018A1 (en) * 2018-11-01 2020-05-07 Yeditepe Universitesi A medicine for treatment of psoriasis and production method thereof

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374957A (en) 1981-10-29 1983-02-22 Michigan Molecular Institute Triblock polymers of a monovinyl aromatic compound and myrcene
US4564718A (en) 1984-08-14 1986-01-14 The University Of Manchester Institute Of Science And Technology Functionally terminated polymers from terpene monomers and their applications
US4713243A (en) 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
JPS63179908A (ja) * 1987-01-22 1988-07-23 Japan Synthetic Rubber Co Ltd ミルセン重合体およびその製造方法
DE3820218A1 (de) 1988-06-14 1989-12-28 Osama L M Dr Med Dr Rer N Omer Phytotherapeutikum zur behandlung von depressivem syndrom
US8178516B2 (en) 1992-06-30 2012-05-15 Sylvan Labs, LLC Compositions and method for treatment of chronic inflammatory diseases
US5506406A (en) 1993-05-17 1996-04-09 Atomic Energy Corporation Of South Africa Ltd. Method and apparatus for determining the concentration of a heavy element in a rock face
US5759569A (en) 1995-01-10 1998-06-02 The Procter & Gamble Company Biodegradable articles made from certain trans-polymers and blends thereof with other biodegradable components
US5714007A (en) 1995-06-06 1998-02-03 David Sarnoff Research Center, Inc. Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
GR950100243A (el) 1995-06-28 1997-02-28 �. �����- �. ����� �.�.�. Χρησιμοποιηση της φυσικης μαστιχας χιου η του εξαγομενου εξ'αυτης φυσικου μαστιχελαιου η συνθετικων παραγωγων του για την παρασεκυη οδοντοκρεμας, οδοντικου διαλυματος, αποσμητικου στοματος, αντιηλιακων, προιοντων μαλλιων, καθως και καλλυντικων προιοντων.
JPH10130254A (ja) * 1996-11-01 1998-05-19 Jumoku Seiri Kinousei Butsushitsu Gijutsu Kenkyu Kumiai ジヒドロクマリン系化合物およびエストロゲン作用剤
DE19646392A1 (de) 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
GR1003541B (el) 1999-05-11 2001-03-07 Αντιμικροβιακη και αντιμυκητιακη δραση του εξαγομενου απο τα κλαδια, φυλλα και καρπο της μαστιχας χιου -pistacia lentiscus var chia-, μαστιχελαιου, για χρηση σε καλλυντικες, φαρμακευτικες και παραφαρμακευτικεσς εφαρμογες καθως και στην παραγωγη οδοντοτσι
GR1003550B (el) 1999-09-22 2001-03-13 Σταθερο παρασκευασμα ισοεξυλοναφθαζαρινων με πεντα- και τετρα-κυκλικα τριτερπενια, συστατικα φυτικων ελαιορητινων και κομμεων
US6623728B2 (en) 2000-06-30 2003-09-23 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Cosmetic skin care compositions and containing gum mastic
US7056491B2 (en) 2000-11-08 2006-06-06 Wisconsin Alumni Research Foundation Monoterpenes and sesquiterpenes as chemotherapeutic and radiation sensitizers and immunomodulators
GR1003868B (el) * 2001-02-06 2002-04-19 Lavipharm S.A. Αξιολογηση των επουλωτικων, αντιοξειδωτικων και κυτταροστατικων ιδιοτητων της μαστιχας και των συστατικων της, και οι εφαρμογες τους
CA2437578A1 (en) 2001-02-13 2002-08-22 Rivka Cohen Carotenoid-loaded liposomes
US6534548B1 (en) 2001-10-02 2003-03-18 Kimberly-Clark Worldwide, Inc. Isoprenoid compositions for the inhibition of exoprotein production from gram positive bacteria
US20050238740A1 (en) 2002-05-01 2005-10-27 Spiros Fotinos Use of mastic and its components for the control of microbial infections
JP2004083443A (ja) 2002-08-23 2004-03-18 Hideji Watanabe マスティックを用いた歯周病予防・治療用組成物及び歯周病予防・治療方法
AU2003303342A1 (en) 2002-12-20 2004-07-22 Exxonmobil Chemical Patents, Inc. Polymers with new sequence distributions
WO2004058828A1 (en) 2002-12-20 2004-07-15 Exxonmobil Chemical Patents Inc. Polymerization processes
US20050074509A1 (en) 2003-10-02 2005-04-07 Data Medica Padova S.P.A. Cancer treatment using natural plant products or essential oils extracted from some pistacia species or components
CA2548430A1 (en) 2003-12-08 2005-06-16 Kenneth John Falk Plant materials extraction method
JP4831488B2 (ja) 2004-03-04 2011-12-07 独立行政法人理化学研究所 アイソタクチック3,4−イソプレン系重合体
WO2005112967A2 (en) 2004-05-19 2005-12-01 Balfour Marketing Corp. Anticancer activity of chios mastic gum
CA2572870A1 (en) 2004-07-06 2006-01-12 Transpharma Medical Ltd. Delivery system for transdermal immunization
CN101068559B (zh) 2004-07-23 2011-08-31 福生生物科技股份有限公司 红球姜的抗超敏炎症和抗敏活性
EP2263663A1 (en) 2004-11-13 2010-12-22 Metaproteomics, LLC Compositions comprising curcuminoids and either alpha or beta acids for use in the treatment of diabetes
US20070036873A1 (en) 2005-07-27 2007-02-15 Shibnath Ghosal Method of treatment or management of stress
US20070148187A1 (en) 2005-12-27 2007-06-28 Intact Enterprises, Inc. Mastic gum composition for use as a dietary supplement in humans and animals
AR060847A1 (es) 2007-05-03 2008-07-16 Spannagel Lucia Antonia Formulacion a base de calendula, aloe y centella.
PL2403512T3 (pl) 2009-03-04 2019-10-31 Regenera Pharma Ltd Kompozycje polimerowego mircenu
DK2403505T3 (en) * 2009-03-04 2017-03-06 Regenera Pharma Ltd Therapeutic Applications of Mastic Rubber Fractions

Also Published As

Publication number Publication date
WO2010100651A2 (en) 2010-09-10
BRPI1013222B8 (pt) 2021-05-25
WO2010100651A3 (en) 2010-10-28
ES2739033T3 (es) 2020-01-28
US8722105B2 (en) 2014-05-13
US10806763B2 (en) 2020-10-20
US9655938B2 (en) 2017-05-23
HK1218710A1 (zh) 2017-03-10
US20170252387A1 (en) 2017-09-07
US20190255132A1 (en) 2019-08-22
AU2010220057B2 (en) 2015-04-02
US20140294928A1 (en) 2014-10-02
IL214923A (en) 2016-10-31
AU2010220057C1 (en) 2015-10-29
EA021833B1 (ru) 2015-09-30
EA201190170A1 (ru) 2013-01-30
PL2403512T3 (pl) 2019-10-31
US10307449B2 (en) 2019-06-04
CN102413834A (zh) 2012-04-11
IL248056A0 (en) 2016-11-30
EA201492273A1 (ru) 2015-04-30
US20120039992A1 (en) 2012-02-16
WO2010100651A4 (en) 2010-12-23
CN105147759A (zh) 2015-12-16
BRPI1013222B1 (pt) 2021-03-16
IL248056B (en) 2019-07-31
BRPI1013222A2 (pt) 2017-09-26
AU2010220057A1 (en) 2011-10-13
EP2403512A2 (en) 2012-01-11
DK2403512T3 (da) 2019-07-22
CA2754565A1 (en) 2010-09-10
EP2403512B1 (en) 2019-05-15
CN102413834B (zh) 2016-11-09
EP3578191A1 (en) 2019-12-11
TR201911270T4 (tr) 2019-08-21
CA2754565C (en) 2020-12-29
IL214923A0 (en) 2011-11-30

Similar Documents

Publication Publication Date Title
IL248056B (en) Compounds of polymeric myrcene
IL217949A0 (en) Pesticdal compositions
EP2488022A4 (en) Compositions
ZA201109176B (en) Homeglobin compositions
IL217881A0 (en) Polymer compositions
GB0906515D0 (en) Fungical compositions
HUE038234T2 (hu) Bendamusztin és ciklopoliszacharid kompozíciók
IL218741A0 (en) Sanitizing compositions
PL2516478T3 (pl) Modyfikowane kompozycje polimerowe
ZA201109312B (en) Compositions
PL2516474T3 (pl) Modyfikowane kompozycje polimerowe
EP2408862A4 (en) POLYMER COMPOSITIONS OF BIOLOGICAL ORIGIN
GB0910046D0 (en) Novel compositions
EP2418244A4 (en) RUBBER COMPOSITION
PL2226355T3 (pl) Kompozycje poliolefinowe sieciowane wilgocią
GB0901966D0 (en) Composition
GB0910045D0 (en) Novel compositions
EP2404987A4 (en) PERFUME COMPOSITIONS
EP2394634A4 (en) HESPERIDO-CONTAINING COMPOSITION
EP2510033A4 (en) IMPROVED ELASTOMERIC COMPOSITIONS
EP2485807A4 (en) SUN PROTECTION COMPOSITIONS
GB0905165D0 (en) Compositions
EP2444061A4 (en) COMPOSITION CONTAINING APIGENIN
ZA201301490B (en) Fragranced spoap compositions
GB0902917D0 (en) Composition